
The Library
Treatments for macular oedema following central retinal vein occlusion : systematic review
Tools
Ford, John A., Clar, C., Lois, Noemi, Barton, Samantha, Thomas, Sian, Court, Rachel A., Shyangdan, D. and Waugh, Norman (2014) Treatments for macular oedema following central retinal vein occlusion : systematic review. BMJ Open, Volume 4 (Number 2). Article Number e004120. doi:10.1136/bmjopen-2013-004120 ISSN 2044-6055.
![]() |
PDF
WRAP_BMJ Open-2014-Ford-.pdf - Requires a PDF viewer. Available under License Creative Commons Attribution Non-commercial. Download (1171Kb) |
Official URL: http://dx.doi.org/10.1136/bmjopen-2013-004120
Abstract
Objectives To review systematically the randomised controlled trial (RCT) evidence for treatment of macular oedema due to central retinal vein occlusion (CRVO).
Data sources MEDLINE, EMBASE, CDSR, DARE, HTA, NHSEED, CENTRAL and meeting abstracts (January 2005 to March 2013).
Study eligibility criteria, participants and interventions RCTs with at least 12 months of follow-up assessing pharmacological treatments for CRVO were included with no language restrictions.
Study appraisal and synthesis methods 2 authors screened titles and abstracts and conducted data extracted and Cochrane risk of bias assessment. Meta-analysis was not possible due to lack of comparable studies.
Results 8 studies (35 articles, 1714 eyes) were included, assessing aflibercept (n=2), triamcinolone (n=2), bevacizumab (n=1), pegaptanib (n=1), dexamethasone (n=1) and ranibizumab (n=1). In general, bevacizumab, ranibizumab, aflibercept and triamcinolone resulted in clinically significant increases in the proportion of participants with an improvement in visual acuity of ≥15 letters, with 40–60% gaining ≥15 letters on active drugs, compared to 12–28% with sham. Results for pegaptanib and dexamethasone were mixed. Steroids were associated with cataract formation and increased intraocular pressure. No overall increase in adverse events was found with bevacizumab, ranibizumab, aflibercept or pegaptanib compared with control. Quality of life was poorly reported. All studies had a low or unclear risk of bias.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Subjects: | R Medicine > RE Ophthalmology | ||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
Library of Congress Subject Headings (LCSH): | Eye -- Diseases -- Treatment, Edema -- Treatment, Retina -- Blood vessels -- Diseases, Systematic reviews (Medical research) | ||||
Journal or Publication Title: | BMJ Open | ||||
Publisher: | BMJ | ||||
ISSN: | 2044-6055 | ||||
Official Date: | 2014 | ||||
Dates: |
|
||||
Volume: | Volume 4 | ||||
Number: | Number 2 | ||||
Article Number: | Article Number e004120 | ||||
DOI: | 10.1136/bmjopen-2013-004120 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Open Access (Creative Commons) |
Request changes or add full text files to a record
Repository staff actions (login required)
![]() |
View Item |
Downloads
Downloads per month over past year